232 related articles for article (PubMed ID: 29930276)
21. Krüppel-like factor 4 promotes high-mobility group box 1-induced chemotherapy resistance in osteosarcoma cells.
Huang J; Liu K; Song D; Ding M; Wang J; Jin Q; Ni J
Cancer Sci; 2016 Mar; 107(3):242-9. PubMed ID: 26676883
[TBL] [Abstract][Full Text] [Related]
22. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
[TBL] [Abstract][Full Text] [Related]
23. Metformin reduces SATB2-mediated osteosarcoma stem cell-like phenotype and tumor growth via inhibition of N-cadherin/NF-kB signaling.
Xu HY; Fang W; Huang ZW; Lu JC; Wang YQ; Tang QL; Song GH; Kang Y; Zhu XJ; Zou CY; Yang HL; Shen JN; Wang J
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4516-4528. PubMed ID: 29131265
[TBL] [Abstract][Full Text] [Related]
24. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
Chen F; Mo J; Zhang L
Tumour Biol; 2016 Oct; 37(10):13403-13412. PubMed ID: 27460090
[TBL] [Abstract][Full Text] [Related]
25. KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas.
Tang H; Zhu H; Wang X; Hua L; Li J; Xie Q; Chen X; Zhang T; Gong Y
J Mol Cell Biol; 2017 Aug; 9(4):315-324. PubMed ID: 28651379
[TBL] [Abstract][Full Text] [Related]
26. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
[TBL] [Abstract][Full Text] [Related]
27. Cancer stem cells in osteosarcoma.
Brown HK; Tellez-Gabriel M; Heymann D
Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
[TBL] [Abstract][Full Text] [Related]
28. Development of Stemness in Cancer Cell Lines Resistant to the Anticancer Effects of Zoledronic Acid.
Yoshiyama A; Morii T; Ohtsuka K; Ohnishi H; Tajima T; Aoyagi T; Mochizuki K; Satomi K; Ichimura S
Anticancer Res; 2016 Feb; 36(2):625-31. PubMed ID: 26851017
[TBL] [Abstract][Full Text] [Related]
29. Selective anticancer effects of a synthetic flavagline on human Oct4-expressing cancer stem-like cells via a p38 MAPK-dependent caspase-3-dependent pathway.
Emhemmed F; Ali Azouaou S; Thuaud F; Schini-Kerth V; Désaubry L; Muller CD; Fuhrmann G
Biochem Pharmacol; 2014 May; 89(2):185-96. PubMed ID: 24607276
[TBL] [Abstract][Full Text] [Related]
30. Dioscin inhibits stem-cell-like properties and tumor growth of osteosarcoma through Akt/GSK3/β-catenin signaling pathway.
Liu W; Zhao Z; Wang Y; Li W; Su Q; Jia Q; Zhang J; Zhang X; Shen J; Yin J
Cell Death Dis; 2018 Mar; 9(3):343. PubMed ID: 29497056
[TBL] [Abstract][Full Text] [Related]
31. Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.
Shu X; Liu H; Zhen R; Jie Y; Chen L; Qi H; Wang C; Wang R; Chen D; Ran Y
Oncol Rep; 2020 Jul; 44(1):313-324. PubMed ID: 32377704
[TBL] [Abstract][Full Text] [Related]
32. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
[TBL] [Abstract][Full Text] [Related]
33. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.
Yu F; Li J; Chen H; Fu J; Ray S; Huang S; Zheng H; Ai W
Oncogene; 2011 May; 30(18):2161-72. PubMed ID: 21242971
[TBL] [Abstract][Full Text] [Related]
34. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
35. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
[TBL] [Abstract][Full Text] [Related]
36. NOV inhibits proliferation while promoting apoptosis and migration in osteosarcoma cell lines through p38/MAPK and JNK/MAPK pathways.
Yao J; Weng Y; Yan S; Hou M; Wang H; Shi Q; Zuo G
Oncol Rep; 2015 Oct; 34(4):2011-21. PubMed ID: 26238193
[TBL] [Abstract][Full Text] [Related]
37. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
[TBL] [Abstract][Full Text] [Related]
38. Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment.
Lu H; Tran L; Park Y; Chen I; Lan J; Xie Y; Semenza GL
Cancer Res; 2018 Aug; 78(15):4191-4202. PubMed ID: 29880481
[TBL] [Abstract][Full Text] [Related]
39. CLEFMA Activates the Extrinsic and Intrinsic Apoptotic Processes through JNK1/2 and p38 Pathways in Human Osteosarcoma Cells.
Yang JS; Lin RC; Hsieh YH; Wu HH; Li GC; Lin YC; Yang SF; Lu KH
Molecules; 2019 Sep; 24(18):. PubMed ID: 31505816
[TBL] [Abstract][Full Text] [Related]
40. Advances in the research of osteosarcoma stem cells and its related genes.
Zhang W; Wei L; Weng J; Yu F; Qin H; Wang D; Zeng H
Cell Biol Int; 2022 Mar; 46(3):336-343. PubMed ID: 34941001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
